Aptorum Group (NASDAQ:APM) Stock Price Up 3.5% – Here’s Why

Aptorum Group Limited (NASDAQ:APM)’s stock price was up 3.5% during mid-day trading on Monday . The company traded as high as $1.2250 and last traded at $1.17. Approximately 93,126 shares changed hands during trading, an increase of 99% from the average daily volume of 46,900 shares. The stock had previously closed at $1.13.

Analyst Ratings Changes

APM has been the subject of several analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Aptorum Group in a report on Tuesday, December 16th. Wall Street Zen raised shares of Aptorum Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 11th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Aptorum Group presently has a consensus rating of “Sell”.

Aptorum Group Stock Performance

The firm has a 50 day simple moving average of $1.39 and a 200 day simple moving average of $1.51.

Aptorum Group Company Profile

Aptorum Group Ltd. (NASDAQ: APM) is a global biopharmaceutical company incorporated under the laws of the Cayman Islands and headquartered in Hong Kong. Since its Nasdaq listing in 2018, the company has focused on the discovery, development and commercialization of novel therapeutics and diagnostic products. Aptorum’s research efforts are aimed at addressing unmet medical needs across oncology, metabolic disorders, infectious diseases and neurological conditions.

The company’s diversified pipeline includes both small-molecule and biologic drug candidates, as well as companion diagnostic tools.